Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group

BACKGROUND: Only a minority of prostate cancer patients with adverse pathology and biochemical recurrence (BCR) post radical prostatectomy (RP) experience metastasis and die from prostate cancer. Improved risk prediction models using genomic information may enable clinicians to better weigh the risk...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Badani, Ketan, Thompson, Darby J. S., Buerki, Christine, Davicioni, Elai, Garrison, Jill, Ghadessi, Mercedeh, Mitra, Anirban P., Wood, Penelope J., Hornberger, John
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2013
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3720607/
https://ncbi.nlm.nih.gov/pubmed/23592338
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars